Company / EPS (Diluted)
Moleculin Biotech, Inc. EPS (Diluted) History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.76
FY2021
5-year range
-$1.76 / -$1.76
FY2017-FY2021
Trend
+9.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 6 years, ranging from $-1.95 in FY2020 to $-0.13 in FY2016.
Based on SEC 10-K filings.
-1.76 in FY2021.
Declined from $-0.46 to $-1.76 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, eps (diluted) increased 9.7% year-over-year.
- Peak eps (diluted) was recorded in FY2016.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$1.76 | +9.7% |
| FY2020 | -$1.95 | -323.9% |
| FY2019 | -$0.46 | +13.2% |
| FY2018 | -$0.53 | -32.5% |
| FY2017 | -$0.40 | -207.7% |
| FY2016 | -$0.13 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026